Does Wegovy make you look older? What's really happening to your face

Rapid or significant weight loss from any cause (including GLP-1 medicines) can reduce facial fat volume, which may make features look more angular or aged.
This effect is not unique to semaglutide: it reflects how the body loses fat globally, not just from the areas you'd prefer.
Staying well hydrated, eating enough protein and preserving muscle through resistance activity can all reduce the degree of facial change.
Some people find the effect reverses or softens as their weight stabilises; others address it with skincare or, if appropriate, cosmetic advice from a dermatologist or GP.

You've lost weight on semaglutide and someone's mentioned your face looks a little different. Maybe more drawn, a little older. This is a real phenomenon that has a real name — sometimes called Wegovy face — and it's worth understanding properly before you make any decisions. Wegovy (semaglutide) is a prescription-only medicine: a GPhC-registered prescriber assesses your suitability before any treatment begins, and they're the right person to talk through any concerns about how your body is changing on it.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The science behind facial changes on semaglutide, and what you can actually do

You notice it first in the mirror, not on the scales

You've been losing weight steadily. The clothes fit better, the numbers are moving, and then, there it is. A friend asks if you're tired. A photo looks different from what you expected. The hollowness under your eyes, the sharpness along your jaw. It isn't imagined.

When the body loses fat at a meaningful rate, it draws from stores everywhere, including the face. Subcutaneous facial fat (the padding that gives cheeks their rounded look and softens the areas around the eyes and mouth) reduces alongside the fat elsewhere. The skin, which took years to stretch gradually, doesn't always spring back at the same speed it's lost its underlying volume. The result can be a gaunt or more aged appearance, even at a perfectly healthy weight. This happens with any significant weight loss, from dietary changes, illness, surgery or medicines like semaglutide.

Semaglutide itself isn't doing something specific to your face. It's doing what it's designed to do (reducing overall fat mass) and the face reflects that alongside everything else. The full picture of how semaglutide works makes this clearer: the medicine reduces appetite and slows gastric emptying; the weight loss that follows is a systemic process, not a targeted one.

Why the rate of loss matters more than most people realise

Faster weight loss tends to produce more pronounced facial volume change. The skin has less time to adapt, and muscle mass is more likely to be lost alongside fat if protein intake and activity levels aren't actively maintained. This is one of the reasons clinicians don't simply set the highest dose from week one, the graduated titration schedule exists partly to let the body adjust.

If you're concerned about how your face looks, there are a few genuinely useful habits. One quick check: pinch the skin lightly on the back of your hand and release it. If it snaps back slowly, you may be mildly dehydrated. Dehydration makes skin look duller and more lined. Drink more water and give it 24 hours, it's a small thing, but it's real and it's fast.

Protein adequacy matters too. Adults losing weight on a GLP-1 medicine should aim to keep protein intake up despite reduced appetite, to preserve lean tissue. The NHS's guidance on semaglutide notes the importance of continuing a reduced-calorie diet and increased activity alongside treatment, the activity piece, particularly resistance exercise, is partly about maintaining the muscle that gives faces and bodies their structure. Talk to your prescriber or a dietitian about what that looks like for you specifically.

What tends to help, and what the evidence actually says

There is no clinical trial data specifically on facial appearance as an outcome for semaglutide. What the evidence does support is that facial fat loss is proportional to overall fat loss, that it tends to be more noticeable above a certain amount of total weight lost, and that it can improve or stabilise once weight does. Some people find that reaching a stable weight (rather than continuing to lose) allows the skin to partially adapt.

Practically: good skincare (SPF, moisturiser, retinoids if a dermatologist recommends them), adequate sleep, hydration and protein are the building blocks. If the change is significant enough to bother you, a consultation with a dermatologist or cosmetic physician is the appropriate next step, that sits outside what a weight-loss prescriber manages, but your GP can help direct you.

One thing that's worth setting aside: stopping semaglutide specifically because of facial changes, without a plan for the weight management question, is rarely a straightforward decision. Weight typically returns after stopping, and any facial volume that returns with it may come back unevenly. That conversation belongs with your prescriber, not a forum. There's more to read on related physical changes (some people also notice they feel colder on Wegovy, or ask about warmth and flushing) both of which have their own explanations worth understanding.

When to bring it up with a clinician

If facial changes are distressing you, that's a valid clinical reason to raise them. Your prescriber can discuss whether your current dose, rate of loss or nutritional intake is contributing, and whether any adjustment is appropriate. Stopping, pausing or changing treatment is a decision that needs clinical input, not because of bureaucracy, but because the right answer depends on your individual picture.

At nume, a GPhC-registered prescriber personally reviews every consultation, your questions about physical changes are exactly the kind of thing the aftercare team is there for, seven days a week. If you haven't yet started treatment and are weighing up what to expect, our Wegovy overview covers the full clinical picture, and you can read about how Wegovy affects appearance more broadly. The free consultation is the place to start if you'd like a prescriber to look at your specific situation. Detailed information on facial changes specifically is also covered on our page about Wegovy and facial ageing.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions